drjobs Senior Director US Pricing Contracting Strategy

Senior Director US Pricing Contracting Strategy

Employer Active

1 Vacancy
drjobs

Job Alert

You will be updated with latest job alerts via email
Valid email field required
Send jobs
Send me jobs like this
drjobs

Job Alert

You will be updated with latest job alerts via email

Valid email field required
Send jobs
Job Location drjobs

Princeton, NJ - USA

Yearly Salary drjobs

$ 221500 - 277500

Vacancy

1 Vacancy

Job Description

About Summit:

Ivonescimab known as SMT112 is a novel potential firstinclass investigational

bispecific antibody combining the effects of immunotherapy via a blockade of PD1 with the antiangiogenesis effects associated with blocking VEGF into a single molecule. Ivonescimab displays unique cooperative binding to each of its intended targets with multifold higher affinity when in the presence of both PD1 and VEGF.

Summit has begun its clinical development of ivonescimab in nonsmall cell lung cancer (NSCLC) with three active Phase III trials:

  • HARMONi is a Phase III clinical trial which intends to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFRmutated locally advanced or metastatic nonsquamous NSCLC who have progressed after treatment with a 3rd generation EGFR TKI (e.g. osimertinib).
  • HARMONi3 is a Phase III clinical trial which is designed to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with firstline metastatic NSCLC.
  • HARMONi7 is a Phase III clinical trial which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with firstline metastatic NSCLC whose tumors have high PDL1 expression.

Ivonescimab is an investigational therapy that is not approved by any regulatory authority in Summits license territories including the United States and Europe. Ivonescimab was approved for marketing authorization in China in May 2024. Ivonescimab was granted Fast Track designation by the US Food & Drug Administration (FDA) for the HARMONi clinical trial setting.

Overview of Role:

As a key member of the Market Access leadership team the Senior Director US Pricing & Contracting Strategy will lead the development and of pricing and contracting strategies to ensure optimal market access and reimbursement. This role demands a strategic leader with profound expertise in the US pricing and reimbursement landscape across all US customer channels understanding the interconnectivity among various stakeholders. The individual will be responsible for all aspects of pricing and contracting including price reporting systems government price reporting and contract development.

Role and Responsibilities:

  • Develop and manage robust price reporting systems to ensure accurate and timely reporting of pricing data
  • Oversee government price reporting processes ensuring compliance with all regulatory requirements and guidelines
  • Manage relationships with outsourced service providers to ensure highquality and efficient delivery of pricing and contracting services
  • Average Sales Price (ASP) management ensuring accurate calculation and reporting to support reimbursement strategies
  • Develop and implement contract modeling strategies to optimize pricing and contracting terms enhancing market access and profitability
  • Manage contract operations including rebates and chargebacks to ensure efficient and compliant processing
  • Lead and facilitate the pricing committee ensuring alignment on pricing strategies and decisions across the organization
  • Ensure compliance with state pricing transparency requirements maintaining accurate and uptodate pricing information
  • Develop and maintain a comprehensive archive of price decisions to support strategic planning and compliance
  • All other duties as assigned

Experience Education and Specialized Knowledge and Skills:

  • Bachelors degree in Business Healthcare or a related field; advanced degree preferred
  • Minimum of 12 years of experience in pricing and contracting strategy within the pharmaceutical industry with a focus on oncology and HCPadministered products
  • Proven track record of successful management of price reporting systems and government price reporting
  • Strong understanding of contract operations including rebates and chargebacks
  • Excellent strategic thinking negotiation and relationship management skills
  • Ability to lead crossfunctional teams and drive complex projects to completion
  • Exceptional communication and presentation skills
  • Ability to travel to support business priorities as needed

This role is ideal for a strategic leader who can navigate the complexities of pricing and contracting in the pharmaceutical industry ensuring compliance and optimizing market access and profitability

The pay range for this role is $221500$277500 annually. Actual compensation packages are based on several factors that are unique to each candidate including but not limited to skill set depth of experience certifications and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus stock benefits and/or other applicable variable compensation.

Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summits Talent Acquisition team at to obtain prior written authorization before referring any candidates to Summit.


Required Experience:

Exec

Employment Type

Contract

Department / Functional Area

Market Access

Report This Job
Disclaimer: Drjobpro.com is only a platform that connects job seekers and employers. Applicants are advised to conduct their own independent research into the credentials of the prospective employer.We always make certain that our clients do not endorse any request for money payments, thus we advise against sharing any personal or bank-related information with any third party. If you suspect fraud or malpractice, please contact us via contact us page.